NF-κB Signaling in Ovarian Cancer

por Harrington, Brittney S., Annunziata, Christina M.
Publicado 2019

PARP inhibitors in BRCA1/BRCA2 germline mutation carriers with ovarian and breast cancer

por Annunziata, Christina M, Bates, Susan E
Publicado 2010

Editorial: Inhibiting PARP as a Strategic Target in Cancer

por Zorn, Kristin K., Annunziata, Christina M.
Publicado 2016

In vitro Enrichment of Ovarian Cancer Tumor-initiating Cells

por House, Carrie D., Hernandez, Lidia, Annunziata, Christina M.
Publicado 2015

Topotecan synergizes with CHEK1 (CHK1) inhibitor to induce apoptosis in ovarian cancer cells

por Kim, Marianne K, James, Jana, Annunziata, Christina M
Publicado 2015

Driving Immune Responses in the Ovarian Tumor Microenvironment

por Ning, Franklin, Cole, Christopher B., Annunziata, Christina M.
Publicado 2021

PI3Kδ inhibition causes feedback activation of PI3Kα in the ABC subtype of diffuse large B-cell lymphoma

por Pongas, Georgios N., Annunziata, Christina M., Staudt, Louis M.
Publicado 2017

Smac-mimetic enhances antitumor effect of standard chemotherapy in ovarian cancer models via Caspase 8-independent mechanism

por Hernandez, Lidia F., Dull, Angie B., Korrapati, Soumya, Annunziata, Christina M.
Publicado 2021

Loss of compensatory pro-survival and anti-apoptotic modulator, IKKε, sensitizes ovarian cancer cells to CHEK1 loss through an increased level of p21

por Kim, Marianne K., Min, Dong J., Wright, George, Goldlust, Ian, Annunziata, Christina M.
Publicado 2014

Disulfiram Transcends ALDH Inhibitory Activity When Targeting Ovarian Cancer Tumor-Initiating Cells

por Caminear, Michael W., Harrington, Brittney S., Kamdar, Rahul D., Kruhlak, Michael J., Annunziata, Christina M.
Publicado 2022

Development and Characterization of an Anti-Cancer Monoclonal Antibody for Treatment of Human Carcinomas

por Tsang, Kwong yok, Fantini, Massimo, Mavroukakis, Sharon A., Zaki, Anjum, Annunziata, Christina M., Arlen, Philip M.
Publicado 2022

An IL-15 Superagonist, ALT-803, Enhances Antibody-Dependent Cell-Mediated Cytotoxicity Elicited by the Monoclonal Antibody NEO-201 Against Human Carcinoma Cells

por Fantini, Massimo, David, Justin M., Wong, Hing C., Annunziata, Christina M., Arlen, Philip M., Tsang, Kwong Y.
Publicado 2019

Identification of therapeutic targets applicable to clinical strategies in ovarian cancer

por Kim, Marianne K., Caplen, Natasha, Chakka, Sirisha, Hernandez, Lidia, House, Carrie, Pongas, Georgios, Jordan, Elizabeth, Annunziata, Christina M.
Publicado 2016

The small molecule NSC676914A is cytotoxic and differentially affects NFκB signaling in ovarian cancer cells and HEK293 cells

por Sagher, Ethan, Hernandez, Lidia, Heywood, Callee, Pauly, Gary T, Young, Matthew R, Schneider, Joel, Colburn, Nancy H, Annunziata, Christina M
Publicado 2014

Identification of the O-Glycan Epitope Targeted by the Anti-Human Carcinoma Monoclonal Antibody (mAb) NEO-201

por Tsang, Kwong Y., Fantini, Massimo, Zaki, Anjum, Mavroukakis, Sharon A., Morelli, Maria Pia, Annunziata, Christina M., Arlen, Philip M.
Publicado 2022

Phase 1, open-label study of MEDI-547 in patients with relapsed or refractory solid tumors

por Annunziata, Christina M., Kohn, Elise C., LoRusso, Patricia, Houston, Nicole D., Coleman, Robert L., Buzoianu, Manuela, Robbie, Gabriel, Lechleider, Robert
Publicado 2012

Limited fibrosis accompanies triple-negative breast cancer metastasis in multiple model systems and is not a preventive target

por Brooks, Danielle, Zimmer, Alexandra, Wakefield, Lalage, Lyle, L. Tiffany, Difilippantonio, Simone, Tucci, Fabio C., Illiano, Stephane, Annunziata, Christina M., Steeg, Patricia S.
Publicado 2018

Overcoming the challenges of drug development in platinum-resistant ovarian cancer

por Eskander, Ramez N., Moore, Kathleen N., Monk, Bradley J., Herzog, Thomas J., Annunziata, Christina M., O’Malley, David M., Coleman, Robert L.
Publicado 2023

NF-κB Signaling Modulates miR-452-5p and miR-335-5p Expression to Functionally Decrease Epithelial Ovarian Cancer Progression in Tumor-Initiating Cells

por Kamdar, Rahul D., Harrington, Brittney S., Attar, Emma, Korrapati, Soumya, Shetty, Jyoti, Zhao, Yongmei, Tran, Bao, Wong, Nathan, House, Carrie D., Annunziata, Christina M.
Publicado 2023

IΚΚε cooperates with either MEK or non-canonical NF-kB driving growth of triple-negative breast cancer cells in different contexts

por House, Carrie D., Grajales, Valentina, Ozaki, Michelle, Jordan, Elizabeth, Wubneh, Helmae, Kimble, Danielle C., James, Jana M., Kim, Marianne K., Annunziata, Christina M.
Publicado 2018